ATE363273T1 - Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels - Google Patents

Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels

Info

Publication number
ATE363273T1
ATE363273T1 AT99949394T AT99949394T ATE363273T1 AT E363273 T1 ATE363273 T1 AT E363273T1 AT 99949394 T AT99949394 T AT 99949394T AT 99949394 T AT99949394 T AT 99949394T AT E363273 T1 ATE363273 T1 AT E363273T1
Authority
AT
Austria
Prior art keywords
itaconic acid
regulate
glycolytic metabolism
food
pharmaceutical composition
Prior art date
Application number
AT99949394T
Other languages
English (en)
Inventor
Yoshinobu Kiso
Aki Kusumoto
Eisuke Furuya
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE363273T1 publication Critical patent/ATE363273T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99949394T 1998-10-27 1999-10-25 Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels ATE363273T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30573298 1998-10-27

Publications (1)

Publication Number Publication Date
ATE363273T1 true ATE363273T1 (de) 2007-06-15

Family

ID=17948692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99949394T ATE363273T1 (de) 1998-10-27 1999-10-25 Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels

Country Status (8)

Country Link
US (1) US6620424B1 (de)
EP (1) EP1062954B1 (de)
JP (1) JP4467801B2 (de)
AT (1) ATE363273T1 (de)
DE (1) DE69936190T2 (de)
DK (1) DK1062954T3 (de)
ES (1) ES2286899T3 (de)
WO (1) WO2000024422A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
WO2017142855A1 (en) 2016-02-15 2017-08-24 Artyomov Maxim Immunomodulatory agents and methods of use thereof
JP7396682B2 (ja) * 2018-06-29 2023-12-12 エルゴン ファーマシューティカルズ エルエルシー イタコン酸誘導体の組成物及び使用方法
CN114209684A (zh) * 2021-12-24 2022-03-22 北京谷海天目生物医学科技有限公司 衣康酸在制备预防和/或治疗超重或肥胖药物或预防超重或肥胖的保健品中的应用
CN115590844B (zh) * 2022-10-12 2024-03-15 郑州大学 中康酸在制备用于预防或治疗代谢综合征的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
DE2558551A1 (de) * 1975-12-24 1977-07-21 Laue Hermann Fa Dinatriumitaconat und verfahren zur geschmacksverbesserung von nahrungs- und genussmitteln sowie von futtermitteln
US4938964A (en) * 1987-12-09 1990-07-03 Showa Denko Kabushiki Kaisha External dermatological composition
EP0393607B1 (de) * 1989-04-19 1996-02-21 Otsuka Pharmaceutical Co., Ltd. Phenylcarbonsäurederivate mit einem Heterocyclus
JP3190717B2 (ja) * 1991-12-24 2001-07-23 キッセイ薬品工業株式会社 新規な置換イタコン酸誘導体
WO1998020124A2 (en) * 1996-10-25 1998-05-14 Peter Mose Larsen Diabetes-mediating proteins and therapeutic uses thereof
JPH10327805A (ja) * 1997-06-02 1998-12-15 Yasuma Kk マグネシウム含有食品組成物
JP4100481B2 (ja) * 1997-09-09 2008-06-11 タカラバイオ株式会社 飲食品

Also Published As

Publication number Publication date
EP1062954A1 (de) 2000-12-27
DE69936190T2 (de) 2008-01-24
EP1062954A4 (de) 2002-06-05
US6620424B1 (en) 2003-09-16
DK1062954T3 (da) 2007-09-10
EP1062954B1 (de) 2007-05-30
WO2000024422A1 (en) 2000-05-04
DE69936190D1 (de) 2007-07-12
ES2286899T3 (es) 2007-12-01
JP4467801B2 (ja) 2010-05-26

Similar Documents

Publication Publication Date Title
BR0004884A (pt) Composições acaricidas
BR9808948A (pt) Composição de confeitaria
IL152554A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII
ES2116421T3 (es) Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente.
CA2331395A1 (en) Fatty acid analogues for the treatment of diabetes
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DE69403656D1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ATE291424T1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
DE69936190D1 (de) Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels
BR0307696A (pt) Composição desodorante ou antitranspirante
DE50200148D1 (de) Mittel zur Bekämpfung von Mikroorganismen, enthaltend einen wirksamen Gehalt an Estern des Polyglycerins
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
BR9301375A (pt) Composicao cosmetica
AR011476A1 (es) Nitrometilcetonas, su procedimiento de preparacion, composiciones que las contienen y su utilizacion para preparar medicamentos.
DE50207110D1 (de) Kombinationspräparat zur behandlung des diabetes mellitus
WO2002051404A8 (fr) Compositions orales
DE60225939D1 (de) Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung
DK0998929T3 (da) Topiske farmaceutiske sammensætninger til sårheling omfattende borneol og bismuthsubgallat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1062954

Country of ref document: EP

EEIH Change in the person of patent owner